Libya campaign was wake-up call for EU nations

April 26, 2012
ForceParis, April 26: The global economic crisis and the subsequent drop in defence budget allocations forced the European Union to heavily depend on American assets for defence operational needs.

The EU's operational limitations and overdependence on US assets were exposed during last year operations in Libya and even on earlier occasions in Kosovo.

“The operations over Libya was a wake-up call for the EU nations which set the alarm bells ringing,” says European Defence Agency communication head Eric Platteau. The Americans, during the Libya campaign, told EU nations in no uncertain terms not to bank on its assets all the time, he added.

EU's Air-to-Air Refueling capacity was no match to the US assets. The European Defence Agency in its recent internal report has even admitted that the “Europeans cannot even sustain a mid-size air operation at this time.” Eric Platteau explains how Europe can field just 42 aircraft of ten different types as compared to US resources of a whopping 650 aircraft of four different types.

This major shortfall in European Union defence capability has left Europeans with some serious mulling over polling and sharing of its defence assets.

The idea is to put in place a systematic European approach that builds up joint defence capabilities that can be used by EU and Nato. But the constrains cannot be overlooked. In the two years, from 2008 to 2010, following the economic crisis, the overall defence expenditure of the 26 European Defence Agencies (EDA) participating member states has decreased by almost 5 per cent. In 2009, the fall in defence budget was estimated at 3.7 per cent.

The Europeans have already begun work on enhancing air-to-air refueling capabilities. The EDA is underway with its efforts to facilitate and harmonise the acquisition of additional air-to-air capabilities.

“We are creating all possible synergies in the logistics, training and operational functions. We are also working on to increase the number of contributing member states by polling and sharing air-to-air assets and services,” Eric told Indian journalists in Brussels.

He added that the mandate by the ministers of defence is to develop this capability on priority and make this available for potential use on EU, Nato and other operations.

Another area of utmost concern for the EU is its relative weakness of the indigenous European Intelligence Surveillance and Reconnaissance (ISR) which was at the fore during the Libya campaign.


Eric maintains that all operational, legal and humanitarian aspects of current and future operations will require even greater precision. “Greater ISR is the key. The way forward is to add-on capacities in sensors, networks. Standardising image formats and network architectures are issues that are being looked into,” he said.

The EU's polling and sharing model is being applies to its Helicopter Training Programme as well. The EDA is also planning to organise two military exercises in 2012 — Hot Blade 12 which is being hosted by Portugal and Green Blade 12 which is hosted by Belgium.


Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 28,2020

Geneva, Apr 28: The global death toll from the novel coronavirus has increased over the past 24 hours by nearly 5,000 to top 198,000, the World Health Organisation (WHO) said.

According to the latest WHO data, 85,530 new cases of infection have been registered globally over the past day, with 4,982 deaths.

The overall number of COVID-19 cases worldwide increased to 2,878,196 and the death count reached 198,668.

There are 1,359,380 confirmed cases and 124,525 deaths in Europe.

The number of cases in the Americas total 1,140,520, with 58,492 deaths.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 26,2020

Apr 26: The Chinese city of Wuhan, where the global coronavirus pandemic began, now has no remaining cases in its hospitals, a health official told reporters on Sunday.

"The latest news is that by April 26, the number of new coronavirus patients in Wuhan was at zero, thanks to the joint efforts of Wuhan and medical staff from around the country," National Health Commission spokesman Mi Feng said at a briefing.

The city had reported 46,452 cases, 56% of the national total. It saw 3,869 fatalities, or 84% of China's total.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.